Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction

Completed · Phase 3

Conditions studied: Ocular Hypertension, Open Angle Glaucoma

In brief

This study is designed to see how safe and effective a new eye drop, called Reformulated PG324, is for lowering eye pressure in people with open-angle glaucoma (OAG) or ocular hypertension (OHT).

Key facts

Study ID
NCT07082816
Run by
Alcon Research
People needed
489
Starts
2025-09-02
Expected to finish
2026-04-06
Last updated by the study team
2026-04-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.